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Today… 
• Overview of the APHCRI-funded CRE 
• Focus on intervention trials and 
methodological issues 
• Examples from a CRE trial 
• Dealing with sudden unpredicted changes in 
the policy environment 
– Change of government 
– Change of management 
Chronic disease in rural and remote areas 
• High rates of diabetes, heart and renal disease, preventable 
complications in remote and Indigenous communities 
• Evidence for effectiveness of Primary Health Care based 
interventions which: 
oPrevent progression of established disease (reduce 
hospitalisations) 
oPrevent onset of new disease 
• Different approaches in different communities (resident 
outreach, clinical and health promotion staff) 
 
How do these various models of care translate into 
improved health outcomes for clients?  
 
 
 
 
Research theme 1 
Nutrition and 
physical activity 
opportunities 
Research theme 2 
Substance 
misuse and 
mental health 
Research theme 3 
PHC Management of diabetes, 
renal CVD and Mental Health 
 
Prevention Management 
PHC Model and Implementation Fidelity 
Cohort studies  
Economic evaluation 
Policy analysis 
Workforce analysis 
Translating research into policy 
• Through interventional and observational research 
demonstrate the impact on health and patient-important 
outcomes of different models of PHC and community-
based prevention on chronic disease risk 
 
• Over time, evaluate place-based interventions on chronic 
disease risk factors and avoidable hospitalisations in large 
cohorts utilising record linkage 
 
• Evaluate these models using economic and other mixed 
methods approaches, including workforce implications 
 
A systems approach to improving 
health outcomes in individuals with 
chronic conditions in rural and 
remote settings: lessons from a 
“failed” trial 
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Intervention trials in health services: 
Pragmatism and serendipity 
• What’s special about Health Services Research 
• Methodological issues 
• Example of “Getting better at chronic care” 
trial 
• What if the trial fails? 
– Theory is wrong 
– Power is insufficient 
– Implementation failure (type 3 error) 
What’s special about health services (and 
much public health) research? 
• Interventions are complex 
• Settings are complex 
• Standard control groups may not be 
feasible/ethical/acceptable to services and/or 
communities 
• “Contamination” is a problem 
• Unmeasured bias/confounding 
• Secular behaviour and policy change over time can be 
strong, sudden and unpredictable 
• Context is very important but often poorly described 
• Example of the DCP 
“Improving reporting quality” 
checklists 
• CONSORT: RCTs with updates for cluster RCTs 
• TREND: Transparent Reporting of Evaluations 
with Non-randomised Designs (focused on HIV 
studies initially) 
• PRISMA: Reporting systematic reviews of RCTs 
• STROBE: Reporting of observational studies 
• MOOSE: Reporting systematic reviews of 
observations studies 
Complex interventions 
 
• Review of RCTs reported over a decade 
• Less than 50% had sufficient detail of the intervention 
to enable replication (Glasziou, 2008) 
• Even fewer had a theoretical framework or logic model 
• Systematic reviews of complex interventions often find 
small if any effects, or contradictory findings. This may 
be due to conflating studies without taking account of 
the underlying theory for the intervention (eg 
Segal,2012: Early childhood interventions) 
Getting Better at Chronic Care (GBACC) 
in North Queensland: a cluster RCT of 
community health worker care co-
ordination in remote FNQ settings 
 
Robyn McDermott, Barbara Schmidt, Cilla Preece, Vickie 
Owens, Sean Taylor, Adrian Esterman, Ashim Sinha, Mark 
Wenitong 
 
 
 
 
Problem 
• >60% life expectancy gap due to chronic diseases  
• High burden of obesity, T2DM, incidence of 
complications especially renal, vascular disease: 
(T2DM Prevalence 43% adults, incidence 3% per 
year) 
• Glycemia, albuminuria driving CVD incidence and 
mortality * 
• Better PHC based secondary prevention is key in 
those with established disease 
*(McDermott et al, MJA, 2011) 
Study hypotheses 
That individualised care of adults with complex 
poorly controlled T2DM by community-based 
IHWs will improve:  
• Care Processes (GPMP, TCA, ACC), 
• Clinical control (HbA1c, BP, Lipids); 
• And reduce diabetes-related complications 
(hospitalisations) over 18 months 
1* 
GPMP  
& TCA 
2* 
ACC 
checks 
4 
Improved 
 HbA1c,  
BP,  
Lipids, 
QoL, etc 
3* 
Therapeutic 
action 
Baseline 
measures 
Follow-up measures over 18 months 
GBACC Program logic: IHWs will facilitate GPMP (1) which should generate a 
further set of activities (checks) in the annual cycle of care (ACC) (2), followed by 
appropriate therapeutic action (3), which should lead to improvement in clinical 
outcomes (4) and reduced avoidable hospitalisations (5).  
*(1), (2) and (3) are brokered by the IHW, indicating better client engagement. 
Does having IHW-led case management lead to an improvement in care 
processes, appropriate therapeutic action and clinical outcomes for 
Indigenous adults with poorly controlled diabetes over 18 months? 
5 
Reduced 
diabetes-
related 
hospital-
isations 
GBACC: mixed methods evaluation in 3 
phases 
Phase 1 (Intervention period: March 2012 – Sept 2013) 
•Randomised controlled trial of intensive case management by 
IHWs 
•Process evaluation  of model of care 
Phase 2 (Nov 2013 – Feb 2014) 
•Review of lessons learned 
• Implementation plan 
Phase 3 (May 2014 – June 2015) 
•Economic analysis 
•Rollout of model 
 12 Participating Communities 
*Intervention sites in phase 1 (randomly allocated) 
Torres and NPA HHS 
• Badu* 
• Bamaga 
• Injinoo* 
• New Mapoon 
• Seisia 
• Umagico* 
 
 
Cape York HHS 
• Kowanyama* 
• Mapoon* 
• Mareeba (Mulungu) 
 
Cairns and Hinterland HHS 
• Mossman Gorge (ACYHC)* 
• Napranum 
• Yarrabah (GYHS) 
 
 
 
PHASE 1:  
CONSCONSORT DIAGRAM: GBACC RCT) 
Enrolment: 12 sites recruited and 327 patients assessed as eligible 
Excluded: 114 patients declined to participate 
Group randomisation: 12 sites 
Allocation 
Intervention: 6 sites  
(n=100 patients) 
Received intervention, n=100 
Allocated to waitlist group: 6 sites 
(n=113 patients) 
Follow up 
Lost to follow-up (n=16) 
• Moved away (12) 
• Died (4) 
Lost to follow up (n=6) 
• Moved away (3) 
• Died (2) 
• Withdrew from study (1) 
Analysis 
Analysed for primary outcome, 
n=108 (96%) 
Analysed for primary outcome,  
n= 84 (84%) 
Baseline data collected, n=213 
Baseline socio-demographic characteristics of study 
participants (SD or %) 
  Control (95% CI) Intervention (95% CI) All (95%CI) p-value 
Number of participants 113 100 213   
Mean age (years) 47.8 (46.2-49.5) 47.9 (45.8-50.0) 47.9 (46.6-49.2) 0.948 
Number (%) women 66.4 (57.6-75.2) 58.0 (48.2-67.8) 62.4 (55.9-69.0) 0.208 
Unemployed (%) 52.2 (42.9-61.5) 40.0 (30.3-49.7) 46.5 (39.7-53.2) 0.204 
Did not complete 12 years 
education (%) 
61.9 (52.9-71.0) 73.0 (64.2-81.8) 67.1 (60.8-73.5) 0.344 
Median (IQR) household  income 17420 (12480-33800) 20215 (13585-31200) 18200 (13000-32500) 0.598 
“Not enough money for food” (%) 40.7 (31.6-49.9) 37.0 (27.4-46.6) 39.0 (32.4-45.6) 0.580 
Median score (IQR) TOFLA 90.0 (81.1-94.1)  80.6 (64.9-89.0) 86.1 (71.5-92.1) <0.001 
No of people per household median 
(IQR) 
5 (3-7) 4 (3-7) 4 (3-7) 0.608 
Median AQoL mental health score 
(IQR) max=1 
0.93 (0.89-0.98) 0.93 (0.91-0.94) 0.93 (0.89-0.95) 0.688 
Current smoker (%) 37.6 (28.4-46.8) 40.2 (30.3-50.1) 38.8 (32.1-45.5) 0.231 
Mean BMI (kg/m2)* 33.0 (31.2-34.9) 31.9 (29.9-33.9) 32.5 (31.1-33.8) 0.434 
Did GBACC improve diabetes care processes? 
Care 
process 
done 
Control group n=113 Intervention group n=100 
N % (95% CI) N % (95% CI) 
GPMP  39           34.8 (25.9-43.7) 40 40.4 (30.6-50.2) 
TCA 39          34.8 (25.9-43.7) 36 36.4 (26.8-45.9) 
Care processes (n and % with GPMP, TCA done) at T3 for intervention vs 
control sites in GBACC among all the participants (N=213) at T3 
Intervention sites were 26% more likely to have implemented a GPMP at T3, however 
this did not reach statistical significance (Odds Ratio = 1.26, 95% confidence interval 
0.72-2.22):  
Clinical care processes at baseline and follow up (%) 
  Baseline Endpoint (excluding 22 loss of follow up) 
  Control n=113  Intervention n=100 Control n=107 intervention n=84 
  No % (95% CI) No % (95% CI) No % (95% CI) No % (95% CI) 
Foot check% 50   44.2 (35.0-53.5) 31 31.0 (21.8-40.2) 38 35.5 (26.3-44.7) 26 31.0 (20.9-41.0) 
Seen by DM educator 
% 
46 40.7 (31.6-49.9) 52 52.0 (42.1-61.9) 41 38.3 (29.0-47.6) 44 52.4 (41.6-63.2) 
Seen by dietician % 22 19.5 (12.1-26.8) 30 30.0 (20.9-39.1) 21 19.6 (12.0-27.2) 37 44.0 (33.3-54.8) 
Dentist check % 20          17.7 (10.6-24.8) 13 13.0 (6.3-19.7) 9 8.4 (3.1-13.7) 15 17.9 (9.6-26.5) 
ECG check% 37 32.7 (24.0-41.5) 42 42.0 (32.2-51.8) 34 43.9 (34.4-53.4) 35 40.5 (29.8-51.1) 
Eye check % 54 47.8 (38.5-57.1) 42 42.0 (32.2-51.8) 56 52.3 (42.8-61.9) 37 44.0 (33.3-54.8) 
Smoker % 38 34.5 (25.6-43.5) 34 35.1 (25.5-44.7) 33 31.2 (22.4-40.4) 34 41.5 (30.7-52.2) 
Blood sugar self-
monitor % 
45 40.9 (31.6-50.2) 46 46.0 (36.1-55.9) 63 59.4 (50.0-68.9) 44 52.4 (41.6-63.2) 
Taking insulin% 55 48.7 (39.4-58.0) 40 40.0 (30.3-49.7) 47 43.9 (34.4-53.4) 40 47.6 (36.8-58.4) 
Dyslipidemia % 83 73.5 (65.2-81.7)        84 84.0 (76.7-91.3) 91 85.0 (78.2-91.9) 76 90.5 (84.1-96.8) 
Taking lipid lowering 
medicines% 
5 4.4 (0.6-8.3) 3 3.0 (-0.4-6.4) 3 2.8 (-0.4-6.0) 5 6.0 (0.8-11.1) 
Albuminuria and 
taking ACEi or ARB 
drugs 
46 88.5 (79.6-97.3) 47 88.7 (80.0-97.4) 58 82.9 (73.9-91.8) 51 89.5 (81.4-97.6) 
Adherent to all 
medicines 
53 46.9 (37.6-56.2) 55 55.0 (45.1-64.9) 57 53.3 (43.7-62.8) 41 48.8 (38.0-59.6) 
Had Fluvax 50 44.2 (35.0-53.5) 66 66.0 (56.6-75.4) 51 47.7 (38.1-57.2) 50 59.5 (48.9-70.2) 
Clinical measures: 212 Indigenous adults with poorly 
controlled T2DM, baseline and follow-up at 18 months 
Measure Baseline Endpoint (excluding 22 lost to follow 
up) 
  Control n=113 Intervention n=100 Control n=107 intervention 
n=84 
No. Mean SD No. Mean SD No. Mean SD No. Mean SD 
HbA1c 
  
113      10.6     1.87 99     10.8     2.0 105     10.3 2.2 84     9.8     2.3 
Total 
Cholesterol 
  
87     4.6     1.3 81     4.5    1.3 100        4.7      1.3 79     4.4   1.4 
Trig 
  
86      2.5     1.9 81     2.1    1.4 100        2.7      1.8 79     2.5    1.8 
HDL 
  
72      1.1    0.6 79     0.9    0.2 99     0.9    0.2 78     0.9    0.2 
LDL 
  
65     2.6    1.0 76     2.7    1.1 95     2.6    1.1 71     2.4    0.9 
Weight 
  
89     91.4    19.3 87      89.7    22.6 92      87.4      18.6 81     91.0    23.1 
HbA1c measures at baseline and follow-up by group, absolute 
values 
8.5
9
9.5
10
10.5
11
11.5
Baseline Endpoint
Control
Intervention
GBACC hospitalisations per person year for intervention and 
control sites (2011-2013) 
Did GBACC have an impact on acute, 
diabetes-related hospitalisations? 
Hosp category Control 
T1 
Control T3 Intervention 
T1 
Intervention T3 
DM complications 
as principal Dx 
162 175 134 129 
Pyelonephritis 9 7 6 5 
Cellulitis 10 14 10 6 
Gangrene 3 8 3 4 
Subtotal DM 
complications & 
acute severe 
infections 
184 
 
204 
 
153 144 
% change from 
baseline (95% CI) 
+11%  
(6.1 - 18.8 ) 
-6% 
(-2.5 to -12.7) 
Hospitalisations for acute infections and DM complications were decreased by 6% in 
the intervention group but increased by 11% in the control sites. 
Was there evidence of Implementation 
Failure (type 3 error)? 
Implementation fidelity was assessed from HW reports 
and interviews with staff 
• Major issues with Doctors doing GPMPs 
• Major issues with IHWs being pulled into mainstream 
acute work 
• Major issues with IHWs getting access to clients’ 
electronic records 
• ACC could have been improved if IHWs could initiate 
pathology testing 
• Around half clients in the intervention group were 
“difficult to engage” according to IHW reports 
Effectiveness will vary by Context 
Context elements can include 
 
• Host organization and staff 
• System effects (eg funding model, use of IT, 
chronic care model for service delivery) 
• Target population 
• Policy environment eg major perturbations 
caused by change of government 
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